Dual-Target Weight Loss Treatment Shows Promise ...Middle East

Medscape - News
Dual-Target Weight Loss Treatment Shows Promise
Amycretin — a novel obesity treatment that targets both GLP-1 and amylin receptors — has shown early success in phase 1 testing and will be advanced into phase 3 testing. Medscape Medical News

Hence then, the article about dual target weight loss treatment shows promise was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dual-Target Weight Loss Treatment Shows Promise )

Apple Storegoogle play

Last updated :

Also on site :